Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
4D Molecular Therapeutics | FDMT | 20. nov 2024 | 8.41 | -3.00 |
51Talk Online Education Group ADR | COE | 20. nov 2024 | 15.49 | -0.26 |
5E Advanced Materials | FEAM | 20. nov 2024 | 0.44 | +0.32 |
60 Degrees Pharmaceuticals | SXTP | 20. nov 2024 | 0.92 | 0.00 |
7-10 Yr Trsy Bear 3X Direxion | TYO | 20. nov 2024 | 14.44 | +0.41 |
7-10 Yr Trsy Bull 3X Direxion | TYD | 20. nov 2024 | 24.48 | -0.45 |
7-10 Yr Trsy Ishares | IEF | 20. nov 2024 | 93.59 | -0.15 |
89bio | ETNB | 20. nov 2024 | 7.98 | -0.13 |
8x8 | EGHT | 20. nov 2024 | 2.84 | +5.58 |
908 Devices | MASS | 20. nov 2024 | 2.56 | +3.23 |
99 Acquisition Group | NNAGU | 20. nov 2024 | 10.60 | 0.00 |
9F ADR | JFU | 20. nov 2024 | 1.28 | +7.56 |
A SPAC II Acquisition | ASCB | 20. nov 2024 | 11.19 | 0.00 |
A-Mark Precious Metals | AMRK | 20. nov 2024 | 30.83 | +2.46 |
a.k.a Brands | AKA | 20. nov 2024 | 18.75 | -1.32 |
A.O Smith | AOS | 20. nov 2024 | 71.75 | +0.48 |
A10 Networks | ATEN | 20. nov 2024 | 16.48 | +0.49 |
A2Z Cust2Mate Solutions | AZ | 20. nov 2024 | 6.44 | -3.16 |
AA Mission Acquisition | AAM | 20. nov 2024 | 10.05 | 0.00 |
AAA - A Rated Corporate Bond Ishares | QLTA | 20. nov 2024 | 47.37 | -0.25 |
Aadi Bioscience | AADI | 20. nov 2024 | 2.22 | +0.45 |
AAON | AAON | 20. nov 2024 | 132.05 | +0.68 |
AAR | AIR | 20. nov 2024 | 67.54 | +0.28 |
Abacus Life | ABL | 20. nov 2024 | 8.86 | +5.10 |
Abbott Laboratories | ABT | 20. nov 2024 | 115.93 | -1.02 |
AbbVie | ABBV | 20. nov 2024 | 167.76 | +0.71 |
AbCellera Biologics | ABCL | 20. nov 2024 | 2.67 | -1.48 |
Abeona Therapeutics | ABEO | 20. nov 2024 | 5.75 | -2.38 |
Abercrombie & Fitch | ANF | 20. nov 2024 | 136.81 | -4.05 |
Aberdeen Asia-Pacificome Fund | FAX | 20. nov 2024 | 15.92 | +0.06 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.